Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 2
2002 1
2003 1
2004 2
2005 2
2006 2
2007 3
2008 2
2009 1
2010 1
2012 1
2013 1
2014 1
2017 1
2023 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis.
Grani G, D'Elia S, Puxeddu E, Morelli S, Arvat E, Nervo A, Spiazzi G, Rolli N, Zatelli MC, Ambrosio MR, Ceresini G, Marina M, Mele C, Aimaretti G, Santaguida MG, Virili C, Crescenzi A, Palermo A, Rossetto Giaccherino R, Meomartino L, Castagna MG, Maino F, Trevisan M, De Leo S, Chiofalo MG, Pezzullo L, Sparano C, Petrone L, Di Dalmazi G, Napolitano G, Tumino D, Crocetti U, Bertagna F, Deandrea M, Antonelli A, Mian C, Carbone A, Monti S, Porcelli T, Brigante G, Barbaro D, Alfò M, Ferraro Petrillo U, Filetti S, Durante C. Grani G, et al. Among authors: crocetti u. J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1377-e1384. doi: 10.1210/clinem/dgae559. J Clin Endocrinol Metab. 2025. PMID: 39150986 Free PMC article.
Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.
De Leo S, Brigante G, D'Elia S, Censi S, Madeo B, Morelli S, Nervo A, Repaci A, Sparano C, Stramazzo I, Virili C, Bertagna F, Dondi F, Puxeddu E, Talpacci E, Zatelli MC, Ambrosio MR, Felicetti F, Piovesan A, Petrone L, Adornato V, Trevisan M, Fugazzola L, Mele C, Zavattaro M, Solaroli E, Salituro N, Rossi M, Pagano L, Colapinto A, Basso C, Ceresini G, Marina M, Crocetti U, Massa M, Deandrea M, Retta F, Spiazzi G, Rolli N, Bruno R, Carbone A, Rotondi M, Magri F, Fallahi P, Chiofalo MG, Santaguida MG, Monti S, Porcelli T, Castello R, Sagnella A, Clausi C, Dalmazi GD, Tumino D, Palermo A, Brunetti A, Lania A, Liverani A, Durante C, Petrillo UF, Alfo' M, Filetti S, Grani G. De Leo S, et al. Among authors: crocetti u. J Clin Endocrinol Metab. 2025 Apr 1:dgaf190. doi: 10.1210/clinem/dgaf190. Online ahead of print. J Clin Endocrinol Metab. 2025. PMID: 40165363
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
De Leo S, D'Elia S, Grani G, Dondi F, Bertagna F, Puxeddu E, Morelli S, Piovesan A, Nervo A, Zatelli MC, Gagliardi I, Samà MT, Aimaretti G, Crocetti U, Massa M, Deandrea M, Retta F, Pagano L, Rossi M, Solaroli E, Pezzullo L, Chiofalo MG, Pontecorvi A, Lombardi CP, Antonelli A, Patrizio A, Messuti I, Magri F, Spiazzi G, Ceresini G, Bruno R, Sparano C, Centanni M, Crescenzi A, Tallini G, Marotta V, Madeo B, Mian C, Filetti S, Durante C, Fugazzola L. De Leo S, et al. Among authors: crocetti u. Thyroid. 2023 Nov;33(11):1318-1326. doi: 10.1089/thy.2023.0052. Epub 2023 Oct 19. Thyroid. 2023. PMID: 37725571
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study.
Grani G, Gentili M, Siciliano F, Albano D, Zilioli V, Morelli S, Puxeddu E, Zatelli MC, Gagliardi I, Piovesan A, Nervo A, Crocetti U, Massa M, Samà MT, Mele C, Deandrea M, Fugazzola L, Puligheddu B, Antonelli A, Rossetto R, D'Amore A, Ceresini G, Castello R, Solaroli E, Centanni M, Monti S, Magri F, Bruno R, Sparano C, Pezzullo L, Crescenzi A, Mian C, Tumino D, Repaci A, Castagna MG, Triggiani V, Porcelli T, Meringolo D, Locati L, Spiazzi G, Di Dalmazi G, Anagnostopoulos A, Leonardi S, Filetti S, Durante C. Grani G, et al. Among authors: crocetti u. J Clin Endocrinol Metab. 2023 Jul 14;108(8):1921-1928. doi: 10.1210/clinem/dgad075. J Clin Endocrinol Metab. 2023. PMID: 36795619
Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.
Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, Costante G, Meringolo D, Bruno R, Trulli F, Massa M, Maniglia A, D'Apollo R, Giacomelli L, Ronga G, Filetti S; PTC Study Group. Durante C, et al. J Clin Endocrinol Metab. 2013 Feb;98(2):636-42. doi: 10.1210/jc.2012-3401. Epub 2013 Jan 4. J Clin Endocrinol Metab. 2013. PMID: 23293334
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.
Durante C, Tognini S, Montesano T, Orlandi F, Torlontano M, Puxeddu E, Attard M, Costante G, Tumino S, Meringolo D, Bruno R, Trulli F, Toteda M, Redler A, Ronga G, Filetti S, Monzani F; PTC Study Group. Durante C, et al. Thyroid. 2014 Jul;24(7):1139-45. doi: 10.1089/thy.2013.0698. Epub 2014 May 21. Thyroid. 2014. PMID: 24702238 Free PMC article.
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
Lamartina L, Durante C, Lucisano G, Grani G, Bellantone R, Lombardi CP, Pontecorvi A, Arvat E, Felicetti F, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Crocetti U, Montesano T, Giubbini R, Orlandi F, Aimaretti G, Monzani F, Attard M, Francese C, Antonelli A, Limone P, Rossetto R, Fugazzola L, Meringolo D, Bruno R, Tumino S, Ceresini G, Centanni M, Monti S, Salvatore D, Spiazzi G, Mian C, Persani L, Barbaro D, Nicolucci A, Filetti S. Lamartina L, et al. Among authors: crocetti u. Thyroid. 2017 Dec;27(12):1490-1497. doi: 10.1089/thy.2017.0299. Epub 2017 Nov 10. Thyroid. 2017. PMID: 29020892 Free article.
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.
Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S, Trischitta V. Torlontano M, et al. Among authors: crocetti u. J Clin Endocrinol Metab. 2008 Mar;93(3):910-3. doi: 10.1210/jc.2007-1067. Epub 2007 Dec 11. J Clin Endocrinol Metab. 2008. PMID: 18073314
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
Durante C, Montesano T, Attard M, Torlontano M, Monzani F, Costante G, Meringolo D, Ferdeghini M, Tumino S, Lamartina L, Paciaroni A, Massa M, Giacomelli L, Ronga G, Filetti S; PTC Study Group. Durante C, et al. J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53. doi: 10.1210/jc.2012-1123. Epub 2012 Jun 7. J Clin Endocrinol Metab. 2012. PMID: 22679061
23 results